Axial3D: against COVID-19 Company

Entity: Axial3D

Category: Others (Medical Supplies)

Description: Axial3D is 3D printing anatomical models for the healthcare industry. 3D printing is revolutionizing healthcare and Axial3D is at the forefront of this innovation with a vision to make 3D printing a part of mainstream medical practice. They create precise, patient-specific 3D printed models generated directly from patient CT and MRI scan data. 3D printed models facilitate a better understanding of abnormalities, encourage novel surgical techniques and improve the surgical outcome for patients. Providing a unique Online Ordering Portal to securely upload scans in minutes, their expert team use the latest 3D printing technology to create precise physical 3D printed models of your patient’s anatomy and deliver directly to the consultant.

1. Project: Change of focus to medical supplies against COVID-19

Summary: Axial3D, which employs 25 people, has pivoted away from its usual work of providing 3D models for surgeons into making items for the fight against Covid-19. That has involved making parts for test kits, masks, face shields and ventilators. Axial3D has sent tens of thousands of swabs for testing for coronavirus to the US. And as well as sending swabs for nasal testing for the virus to the US, it's distributed 30,000 face shields made though its 3D printing technology. To help with distribution it joined forces with Locate a Locum, which works with pharmacies, and taxi service FonaCab. Axial3D chief technology officer Niall Haslam said: "Our core expertise is in medical visualisation, using two-dimensional images in the making of 3D printed objects and anatomical models for surgeons."

2. Project: Helping tackle the surgical backlog caused by COVID-19

Summary: The patient insights provided by a 3D anatomical model can reduce OR time by over 60 minutes on average. Axial3D is offering a free customised 3D model to support health care professionals as they restart surgical services.

+ Investors:

Innovation Ulster
Ulster University
Imprimatur Capital Fund Management
Clarendon Fund Managers
Techstart Ventures

Headquarters: United Kingdom
Funding Status: N/A
Employee Number: N/A
Investment Stage: N/A
Number Of Exists: N/A
Technology: Others
Investor Type: N/A
Founded Date: N/A
Industry: UK COVID